Information displayed below is a subset of the entire knowledge base and may be incomplete intensionally or inadvertently. If you detect a serious error or want access to the complete knowledge base, please contact us.
Dalfampridine (Ampyra) is a prescription medication used to improve walking in adults with multiple sclerosis (MS). It is a potassium channel blocker that works by increasing the speed of nerve conduction in the central nervous system.
Common side effects of dalfampridine include headache, dizziness, insomnia, nausea, and urinary tract infection. More serious side effects may include seizures, confusion, and chest pain.
Brand names associated with dalfampridine include Ampyra, Fampyra, and Vazculep.
All of the following must be considered when interpreting clinical findings
and are too extensive to be covered on this site: